clinical trial · NCT07734415
Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
Inmagene LLC·phase2·enrolling by invitation·n = 400
Atopic DermatitisAtopic Dermatitis EczemaEczemaIMG-007
brief summary
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic dermatitis (AD)
started
Jun 5, 2026
primary completion
Mar 1, 2028
completion
Mar 1, 2028
last updated
Jul 29, 2026
official title
A Long-term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous IMG-007 in Participants of a Previous IMG-007 Moderate-To-Severe Atopic Dermatitis Clinical Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol